Acetaminophen autism mass tort

Acetaminophen autism mass tort refers to U.S. product-liability lawsuits alleging that in utero exposure to acetaminophen (also known as paracetamol and sold under brand names including Tylenol) increased the risk of autism spectrum disorder (ASD) and/or attention deficit hyperactivity disorder (ADHD) in children. Many of the federal cases were centralized in multidistrict litigation (MDL) in the Southern District of New York, but the MDL was largely dismissed after the court excluded plaintiffs' general-causation experts under federal evidence standards, a decision that was later the subject of appellate review and continuing public controversy.[1]

Background

Acetaminophen is a widely used analgesic and antipyretic, including during pregnancy. Scientific research on prenatal acetaminophen exposure and neurodevelopmental outcomes has produced mixed findings, with some observational studies reporting associations and others finding no association once familial and confounding factors are addressed.[2][3]

In 2025, the American College of Obstetricians and Gynecologists (ACOG) stated that evidence was insufficient to establish a causal relationship between acetaminophen use in pregnancy and neurodevelopmental outcomes, while advising clinicians and patients to use medications only as needed and as directed.[4]

Federal litigation

On October 5, 2022, the U.S. Judicial Panel on Multidistrict Litigation (JPML) transferred[5] some 66 autism and ADHD lawsuits[6] to Senior District Judge Denise Cote in the Southern District of New York, thus consolidating all such acetaminophen birth defect cases in a mass tort.[7] The case specifically concerns the lack of warning regarding in utero use. On November 19 Judge Cote, among other matters, ruled against Walmart's preemption argument (which is often raised in pharmaceutical mass tort cases). Judge Cote likewise ruled against Johnson & Johnson in April 2023.[8] Given the significant media attention and advertising the class action has been receiving, the number of plaintiffs was widely anticipated to increase considerably.[9][10]

The case was thrown out December 18, 2023,[11] with Judge Cote writing in 148-page ruling[12] "The unstructured approach adopted by the plaintiffs' experts permitted cherry-picking, allowed a results-driven analysis, and obscured the complexities, inconsistencies, and weaknesses in the underlying data..."[13]

In October 2025, the Texas Attorney General filed a consumer-protection lawsuit against Johnson & Johnson and Kenvue (which markets Tylenol in the U.S.), alleging deceptive marketing of acetaminophen as safe during pregnancy and asserting a link to autism and other developmental disorders; news coverage described the scientific link as unproven and noted that many related federal cases had been dismissed and were under appeal.[14][15]

See also

References

  1. ^ Jones, Diana Novak (November 17, 2025). "Judges question dismissal of private Tylenol lawsuits". Reuters. Retrieved February 23, 2026.
  2. ^ Ahlqvist, V. H. (2024). "Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability". JAMA. 331 (14): 1205–1214. doi:10.1001/jama.2024.3172. PMC 11004836. PMID 38592388.
  3. ^ D'Antonio, F. (2025). "Prenatal paracetamol exposure and child neurodevelopment". The Lancet Regional Health – Europe. Retrieved February 23, 2026.
  4. ^ "Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes". American College of Obstetricians and Gynecologists. September 22, 2025. Retrieved February 23, 2026.
  5. ^ "Transfer Order" (PDF). United States Judicial Panel on Multidistrict Litigation. 2022-10-05. Retrieved 2022-11-21.
  6. ^ Pierson, Brendan (2022-10-06). "Mass tort launched for claims that acetaminophen caused autism, ADHD". Reuters. Retrieved 2022-11-21.
  7. ^ Jackson, Irvin (2022-10-06). "Acetaminophen Lawsuits Over Autism and ADHD Risks Centralized in Federal MDL". AboutLawsuits.com. Retrieved 2022-11-21.
  8. ^ "Acetaminophen on trial over possible links to autism, ADHD". Spectrum | Autism Research News. April 26, 2023.
  9. ^ Auchmuty, Matthew (2022-11-20). "Settlements for Tylenol Autism Lawsuits". Dolman Law Group. Retrieved 2022-11-21.
  10. ^ Miller, Ronald V.; Jr. (2022-11-19). "Tylenol Autism Lawsuit". Lawsuit Information Center. Retrieved 2022-11-21.
  11. ^ Mulvaney, Erin (19 December 2023). "Court Rejects Claims Linking Tylenol to Autism, ADHD". WSJ. Retrieved 2024-01-03.
  12. ^ "Opinion | Trump, Tylenol and the Plaintiffs Bar". The Wall Street Journal. Sep 23, 2025.
  13. ^ "IN RE: Acetaminophen – ASD-ADHD Products Liability Litigation" (PDF). Retrieved 2024-01-03.
  14. ^ "Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk". Associated Press. October 2025. Retrieved February 23, 2026.
  15. ^ "Texas sues Tylenol, taking cues from Trump and RFK Jr". The Washington Post. October 28, 2025. Retrieved February 23, 2026.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.